McNeil Lowers Recommended Maximum Dose For Extra Strength Tylenol
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare lowers the maximum daily dose indicated on labels of Extra Strength Tylenol, the first in a series of dosing changes for the firm’s acetaminophen-containing products.
You may also be interested in...
Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
OTC Acetaminophen Label Guidance For Liver Warning Clarifies Ingredient Specifics
FDA allows marketers of acetaminophen-containing OTC products to use an alternative liver warning, according to an updated guidance. The change from the draft, which aligns with a request by CHPA, separates maximum dosage for the ingredient from the dosage included in a certain product.